Oscotec Inc. (039200.KQ)
KRW 30900.0
(1.15%)
KRW 30900.0
(1.15%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 35.57 Billion KRW | 12.63% |
| 2022 | 30.08 Billion KRW | 5.11% |
| 2021 | 28.62 Billion KRW | -31.37% |
| 2020 | 41.7 Billion KRW | 76.64% |
| 2019 | 23.61 Billion KRW | 140.54% |
| 2018 | 9.81 Billion KRW | 26.58% |
| 2017 | 7.75 Billion KRW | 121.8% |
| 2016 | 3.49 Billion KRW | -52.82% |
| 2015 | 7.4 Billion KRW | -19.48% |
| 2014 | 9.2 Billion KRW | -27.42% |
| 2013 | 12.67 Billion KRW | -23.1% |
| 2012 | 16.48 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.18 Billion KRW | -14.05% |
| 2024 Q2 | 7.95 Billion KRW | 2.61% |
| 2023 Q1 | 7.85 Billion KRW | 27.12% |
| 2023 Q3 | 8.76 Billion KRW | 13.07% |
| 2023 Q4 | 9.52 Billion KRW | 8.69% |
| 2023 FY | 33.88 Billion KRW | 12.63% |
| 2023 Q2 | 7.74 Billion KRW | -1.4% |
| 2022 Q4 | 6.18 Billion KRW | -19.7% |
| 2022 Q3 | 7.69 Billion KRW | 5.63% |
| 2022 Q1 | 8.94 Billion KRW | 87.45% |
| 2022 FY | 30.08 Billion KRW | 5.11% |
| 2022 Q2 | 7.28 Billion KRW | -18.49% |
| 2021 Q2 | 6.27 Billion KRW | -40.71% |
| 2021 Q4 | 4.76 Billion KRW | -31.99% |
| 2021 Q1 | 10.58 Billion KRW | -37.14% |
| 2021 FY | 28.62 Billion KRW | -31.37% |
| 2021 Q3 | 7.01 Billion KRW | 11.78% |
| 2020 Q2 | 7.91 Billion KRW | 7.06% |
| 2020 Q1 | 7.39 Billion KRW | 7.99% |
| 2020 Q4 | 16.83 Billion KRW | 111.27% |
| 2020 FY | 41.7 Billion KRW | 76.64% |
| 2020 Q3 | 7.96 Billion KRW | 0.65% |
| 2019 Q2 | 7.74 Billion KRW | 52.28% |
| 2019 FY | 23.61 Billion KRW | 140.54% |
| 2019 Q4 | 6.84 Billion KRW | 47.88% |
| 2019 Q3 | 4.63 Billion KRW | -40.22% |
| 2019 Q1 | 5.08 Billion KRW | 119.76% |
| 2018 Q1 | 1.41 Billion KRW | -41.0% |
| 2018 Q3 | 4.77 Billion KRW | 174.97% |
| 2018 FY | 9.81 Billion KRW | 26.58% |
| 2018 Q4 | 2.31 Billion KRW | -51.49% |
| 2018 Q2 | 1.73 Billion KRW | 22.87% |
| 2017 FY | 7.75 Billion KRW | 121.8% |
| 2017 Q3 | 1.86 Billion KRW | 19.91% |
| 2017 Q4 | 2.39 Billion KRW | 28.47% |
| 2017 Q2 | 1.55 Billion KRW | -31.32% |
| 2017 Q1 | 2.26 Billion KRW | -50.52% |
| 2016 Q3 | 1.42 Billion KRW | -66.64% |
| 2016 Q1 | 966.1 Million KRW | -46.07% |
| 2016 Q2 | 4.26 Billion KRW | 341.57% |
| 2016 FY | 3.49 Billion KRW | -52.82% |
| 2016 Q4 | 4.57 Billion KRW | 221.27% |
| 2015 Q3 | 1.59 Billion KRW | -17.8% |
| 2015 Q4 | 1.79 Billion KRW | 12.11% |
| 2015 Q2 | 1.94 Billion KRW | -9.37% |
| 2015 Q1 | 2.14 Billion KRW | -36.36% |
| 2015 FY | 7.4 Billion KRW | -19.48% |
| 2014 Q1 | 1.64 Billion KRW | -71.88% |
| 2014 FY | 9.2 Billion KRW | -27.42% |
| 2014 Q4 | 3.36 Billion KRW | 62.71% |
| 2014 Q3 | 2.07 Billion KRW | -2.35% |
| 2014 Q2 | 2.12 Billion KRW | 29.3% |
| 2013 Q2 | 2.05 Billion KRW | 16.55% |
| 2013 Q3 | 3.02 Billion KRW | 47.32% |
| 2013 Q1 | 1.76 Billion KRW | -82.21% |
| 2013 Q4 | 5.83 Billion KRW | 92.68% |
| 2013 FY | 12.67 Billion KRW | -23.1% |
| 2012 Q4 | 9.91 Billion KRW | 262.83% |
| 2012 FY | 16.48 Billion KRW | 0.0% |
| 2012 Q3 | 2.73 Billion KRW | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| BCWORLD PHARM. Co., Ltd. | 25.59 Billion KRW | -38.979% |